Scope
12 employees on LinkedIn · 2 known investors
Find your way into Scope
Sign up to find every way you can get introduced to Scope
- Your email: who you already know at Scope, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Scope team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Scopebio develops on-site molecular diagnostic assays for detecting crop pathogens, enabling rapid pathogen identification directly in the field. The company serves agricultural producers and offers custom assay development for emerging threats and niche crops.
Founders & leadership
Investors · 2
SHIFT Investlisted by SHIFT InvestAmstelveen · $270K – $3.3M
How we know: SHIFT Invest's portfolio page · the VCSheet dataset · Not right? Tell us
Index VenturesreportedSan Francisco · $540K – $10.8M
How we know: funding news · press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AMay 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Scope do?
- Scopebio develops on-site molecular diagnostic assays for detecting crop pathogens, enabling rapid pathogen identification directly in the field. The company serves agricultural producers and offers custom assay development for emerging threats and niche crops.
- Who founded Scope?
- Scope was founded by Niek Savelkoul.
- Who are Scope's investors?
- Scope's investors include SHIFT Invest, Index Ventures.

